Best Targeted Therapy Centre in Ahmedabad
Targeted Therapy at Aagam Cancer Centre
Aagam Cancer Centre is known to be the best targeted therapy centre in Ahmedabad and provides the most sophisticated cancer treatment under one roof with Dr Ashish Kaushal, one of the most seasoned medical oncologists in the region. Compared to traditional chemotherapy, targeted therapy is far more precise and effective and is one of the most innovative approaches in cancer care to date. Moreover, we seek to increase the quality of life for cancer patients, and that’s why our facility in Ahmedabad, Gujarat, is fully equipped to incorporate the latest technologies in innovative cancer treatment.
What is Targeted Therapy?
Targeted therapy involves the use of drugs designed to specifically target cancer cells by interfering with specific molecules involved in tumour growth and progression. Unlike conventional chemotherapy, which can affect both cancerous and healthy cells, targeted therapy aims to minimise damage to normal cells, thereby reducing side effects and improving patient well-being.
Common Drugs and Their Benefits in Targeted Therapy
Several targeted therapy drugs are used depending on
the type and stage of cancer. Here are some commonly
used drugs and their benefits:
Bevacizumab (Avastin)
Indications: Bevacizumab is used in the treatment
of colorectal cancer, non-small cell lung cancer
(NSCLC), renal cell carcinoma, and glioblastoma.
Benefits: By inhibiting angiogenesis, Bevacizumab
starves tumors of their blood supply, slowing their
growth. In metastatic colorectal cancer, adding
Bevacizumab to chemotherapy has been shown to
improve progression-free survival (PFS) by
approximately 4 months and overall survival (OS)
by 5 months. In NSCLC, the addition of
Bevacizumab to platinum-based chemotherapy has
improved PFS by 1.5 months and OS by 2 months.
Trastuzumab (Herceptin)
Indications: Trastuzumab is primarily used for
HER2-positive breast cancer and gastric cancer.
Benefits: Trastuzumab targets the HER2 receptor,
inhibiting cancer cell growth. In HER2-positive
breast cancer, it has revolutionized treatment,
increasing 5-year survival rates from 75% to 85%
and reducing the risk of recurrence by 50%. In
gastric cancer, Trastuzumab combined with
chemotherapy has improved median OS by nearly
3 months.
T-DM1 (Trastuzumab Emtansine)
Indications: T-DM1 is used for HER2-positive
metastatic breast cancer, particularly after
progression on Trastuzumab.
Benefits: Combining trastuzumab with a
chemotherapy drug, T-DM1 targets HER2-positive
cancer cells with enhanced precision, leading to
improved survival rates. Clinical trials have shown
that T-DM1 can improve PFS by approximately 3
months and OS by 6 months compared to other
treatments.
Trastuzumab Deruxtecan (Enhertu)
Indications: This drug is used for HER2-positive
breast cancer that has metastasized.
Benefits: Combining trastuzumab with a potent
chemotherapy agent, Trastuzumab Deruxtecan,
has shown significant efficacy. In clinical trials, it
has demonstrated a PFS improvement of around 6
months and an OS benefit of about 8 months in
advanced HER2-positive breast cancer.
Rituximab (Rituxan)
Indications: Rituximab is used for non-Hodgkin’s
lymphoma (NHL), chronic lymphocytic leukemia
(CLL), and rheumatoid arthritis.
Benefits: By targeting the CD20 protein on B-cells,
Rituximab enhances immune system recognition
and destruction of cancer cells. In NHL, adding
Rituximab to chemotherapy has improved 5-year
survival rates by 15-20%. In CLL, Rituximab has
improved PFS by approximately 10 months and OS
by 14 months.
Cetuximab (Erbitux)
Indications: Cetuximab is used for metastatic
colorectal cancer and head and neck squamous
cell carcinoma.
Benefits: Targeting the EGFR protein, Cetuximab
inhibits cancer cell growth. In metastatic colorectal
cancer, adding Cetuximab to chemotherapy has
improved PFS by about 3 months and OS by 4
months. In head and neck cancer, Cetuximab
combined with radiation therapy has improved 5
year survival rates by approximately 10%.
Tyrosine Kinase Inhibitors (TKIs)
Combination Therapy
Combining targeted therapy with other treatments like chemotherapy and immunotherapy can enhance its effectiveness. For instance, the combination of Bevacizumab with Atezolizumab and chemotherapy has shown significant improvements in progression-free survival (PFS) and overall survival (OS) in patients with advanced cancer.
Progression-Free Survival (PFS): Studies have shown that combining Bevacizumab with Atezolizumab and chemotherapy can increase PFS by up to 6 months compared to chemotherapy alone.
Overall Survival (OS): This combination therapy has also been associated with a significant improvement in OS, extending the life expectancy of patients by several months.
Advantages and Benefits of Targeted Therapy
Targeted therapy offers several advantages over conventional chemotherapy, making it a preferred option for many patients:
Higher Precision: By specifically targeting cancer cells, targeted therapy reduces damage to healthy cells, resulting in fewer side effects.
Improved Quality of Life: Patients undergoing targeted therapy often experience a better quality of life due to reduced toxicity and fewer side effects.
Better Outcomes: Clinical trials have demonstrated higher rates of PFS and OS with targeted therapies. For example, in certain types of breast cancer, targeted therapy has increased PFS rates by approximately 30% and OS rates by 20%.
Personalized Care at Aagam Cancer Centre
Aagam Cancer Centre is known to be the best targeted therapy center in Ahmedabad and gives patients a focused and personalized approach to cancer care. As one of the best cancer doctors in Ahmedabad, Dr. Ashish Kaushal and our center seamlessly integrate over two decades of experience with the latest technologies in targeted therapy. We offer all-encompassing treatment plans that we feel meet the requirements of our patients while still providing them with the highest standard of care.
Why choose us
We Help You To Be Healthier
Choosing Aagam Cancer Centre means opting for the best targeted therapy centre in Ahmedabad and selecting a centre that prioritises the patient’s well-being. Our approach and Dr Ashish Kaushal’s experience help ensure better quality of care. Meet us today and find out how targeted therapy can benefit you in your battle against cancer.
Dr Ashish Kaushal is a renowned cancer specialist with extensive experience in targeted therapy, making him one of the best medical oncologists in Ahmedabad.
Our chemotherapy centre offers a range of services, including targeted therapy, immunotherapy, and traditional chemotherapy, ensuring that patients receive the best possible care.
Aagam Cancer Centre is equipped with the latest technology to provide cutting-edge cancer treatments.
Book Your Consultation Today
Don’t wait to get the care you deserve. Schedule your consultation with Dr. Ashish Kaushal at Aagam Cancer Center and explore how cutting-edge immunotherapy can change your life or that of your loved one.
Because hope starts with a conversation.